Trial Review

Did you know?

The ANZCTR now automatically displays published trial results and simplifies the addition of trial documents such as unpublished protocols and statistical analysis plans.

These enhancements will offer a more comprehensive view of trials, regardless of whether their results are positive, negative, or inconclusive.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial registered on ANZCTR


Registration number
ACTRN12612000229875
Ethics application status
Approved
Date submitted
22/02/2012
Date registered
23/02/2012
Date last updated
23/02/2012
Type of registration
Prospectively registered

Titles & IDs
Public title
Survey of Community Pharmacy Involvement in Palliative Care
Scientific title
Do all Community Pharmacies within South Australia have the capacity to supply medications for pallative symptoms in a timely manner.
Secondary ID [1] 280012 0
Nil
Universal Trial Number (UTN)
U1111-1128-3682
Trial acronym
Linked study record

Health condition
Health condition(s) or problem(s) studied:
Palliave Care 285919 0
Condition category
Condition code
Public Health 286111 286111 0 0
Health service research

Intervention/exposure
Study type
Observational
Patient registry
Target follow-up duration
Target follow-up type
Description of intervention(s) / exposure
Community pharmacies play a significant role with supporting palliative patients through timely access to medicines. This survey seeks to map the current situation with regards to what services and medicines are available through the community pharmacy network, for palliative patients and their families.
This de-identified information along information on costs and clinical evidence will guide the development of a priority medicines list for palliative patients across South Australia.
This is a one-off survey to identify further projects to connect pharmacy services for this patient group. Data is expected to be returned with a month of receiving the survey
Intervention code [1] 284334 0
Not applicable
Comparator / control treatment
there will not be a comparitor group
Control group
Uncontrolled

Outcomes
Primary outcome [1] 286585 0
To establish which medicines are commonly held in community pharmacies around South Australia that could be prescribed for palliative patients.
A percentage of pharmacies across South Australia that currently hold stock of each specific medication will be calculated. This figure will provide us with a measure of likihood that that specific medication will be held in a pharmacy across the state.
Timepoint [1] 286585 0
One month
Secondary outcome [1] 296219 0
To establish any gaps where medications cannot readily be accessed within the community setting. In comparing data between pharmacies it may be identified that there are particular geographical locations or factors that are linked with reduced capacity to hold specific medications. This will guide us to the development of the priority medicines list as well as a education programme with which priority medications that community pharmacies should hold for our patient population.
Timepoint [1] 296219 0
One month

Eligibility
Key inclusion criteria
All pharmacies within South Australia
Minimum age
No limit
Maximum age
No limit
Sex
Both males and females
Can healthy volunteers participate?
Yes
Key exclusion criteria
none

Study design
Purpose
Screening
Duration
Cross-sectional
Selection
Defined population
Timing
Prospective
Statistical methods / analysis

Recruitment
Recruitment status
Not yet recruiting
Date of first participant enrolment
Anticipated
28/02/2012
Actual
Date of last participant enrolment
Anticipated
Actual
Date of last data collection
Anticipated
Actual
Sample size
Target
478
Accrual to date
Final
Recruitment in Australia
Recruitment state(s)

Funding & Sponsors
Funding source category [1] 284767 0
Hospital
Name [1] 284767 0
The Drug and Therapeutics Information Service (DATIS)
Country [1] 284767 0
Australia
Primary sponsor type
Individual
Name
Paul Tait
Address
Daw House Hospice
700 Goodwood Road
Daw Park SA 5041
Country
Australia
Secondary sponsor category [1] 283658 0
Individual
Name [1] 283658 0
Debra Rowett
Address [1] 283658 0
The Drug and Therapeutics Information Service (DATIS)
700 Goodwood Road
Daw Park SA 5041
Country [1] 283658 0
Australia

Ethics approval
Ethics application status
Approved
Ethics committee name [1] 286761 0
The Research Ethics Office of the Southern Adelaide Local Health Network
Ethics committee address [1] 286761 0
Human Research Ethics Room 2A 221 Flinders Medical Centre Level 2, Flinders Medical Centre BEDFORD PARK SA 5042
Ethics committee country [1] 286761 0
Australia
Date submitted for ethics approval [1] 286761 0
27/01/2012
Approval date [1] 286761 0
17/02/2012
Ethics approval number [1] 286761 0
1/12/0024

Summary
Brief summary
The main objective of this survey is to identify the capacity any pharmacy throughout South Australia has to be able to respond rapidly to the symptom control of palliative patients in the last few days or hours of life. This information will provide us with an objective overview as to how community pharmacies across South Australia currently are able to respond to palliative patients. It will also provide a basis to build approaches which support community pharmacy to respond to meet the needs of palliative care patient’s access to medicines.

De-identified information will be used to:

Guide the development of a priority medicines list for palliative patients across South Australia. This list will be chosen using three factors: clinical evidence, cost and medication accessibility. Where two or more medicines are clinically/cost equivalent we will need to identify which one has greater community accessibility.
Provide feedback to the broader pharmacy community (Australian and overseas) in the form of a report published in a peer reviewed Journal;
Flag factors that limit access to palliative medicines within the community to inform future quality improvement activities
Create a baseline dataset from which to measure changes resulting from the implementation of quality improvement activities

We would like to identify the general spread of responses of pharmacies across the state as well as differences between regions.
Trial website
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 33824 0
Address 33824 0
Country 33824 0
Phone 33824 0
Fax 33824 0
Email 33824 0
Contact person for public queries
Name 17071 0
Paul Tait
Address 17071 0
Daw House Hospice
700 Goodwood road
Daw Park SA 5041
Country 17071 0
Australia
Phone 17071 0
+61 478 407 877
Fax 17071 0
+61 8 8277 4957
Email 17071 0
[email protected]
Contact person for scientific queries
Name 7999 0
Paul Tait
Address 7999 0
Daw House Hospice
700 Goodwood road
Daw Park SA 5041
Country 7999 0
Australia
Phone 7999 0
+61 478 407 877
Fax 7999 0
+61 8 8277 4957
Email 7999 0
[email protected]

No information has been provided regarding IPD availability


What supporting documents are/will be available?

No Supporting Document Provided



Results publications and other study-related documents

Documents added manually
No documents have been uploaded by study researchers.

Documents added automatically
No additional documents have been identified.